The Johnson & Johnson single-dose COVID-19 vaccine that was paused last week by the federal government has been given the green light again, despite 15 blood clots and one death that caused the pause in the first place. The Centers for Disease Control (CDC) and the U.S. Food and Drug Administration (FDA) approved the drug's reentry into the vaccine market for emergency use authorization (EUA). "Following a thorough safety review, including two meetings of the CDC's Advisory Committee on Immunization Practices, the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined that the...